Nir Sassi
Patrimonio netto: 34 518 $ in data 31/07/2026
Patrimonio netto: 34 518 $ in data 31/07/2026
Nir Sassi worked as Senior Manager at PricewaterhouseCoopers (Israel) from 2002 to 2010.
Served as Chief Financial Officer at Intec Pharma Ltd. from 2016 to 2021.
Served as Chief Financial Officer at Indaptus Therapeutics, Inc. from 2021 to 2023.
Completed undergraduate studies at Ben-Gurion University of the Negev.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 22/12/2025 | 26.758 ( 0,02% ) | 34 518 $ | 31/07/2026 |
| Società | Posizione | Fine |
|---|---|---|
| INDAPTUS THERAPEUTICS, INC. | Direttore Finanziario/CFO | 01/04/2026 |
PricewaterhouseCoopers (Israel)
PricewaterhouseCoopers (Israel) Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01/01/2010 |
Intec Pharma Ltd.
Intec Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products to treat neurodegenerative diseases | Direttore Finanziario/CFO | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
PricewaterhouseCoopers (Israel)
PricewaterhouseCoopers (Israel) Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Ben-Gurion University of the Negev
Ben-Gurion University of the Negev Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intec Pharma Ltd.
Intec Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products to treat neurodegenerative diseases | Health Technology |
Indaptus Therapeutics, Inc.
Indaptus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale